Special Issue "Botulinum Toxins in Clinical Practice"
Deadline for manuscript submissions: 31 October 2021.
The study of botulinum neurotoxin (BoNT) extends beyond the treatment of neurologic disorders and facial wrinkles to include many off-label uses in clinical practice. With more and more studies being published, it is crucial for researchers to collect up-to-date scientific achievements in the emerging clinical applications of BoNT. In fact, what we still lack is the scientific evidence of less-investigated clinical applications of BoNT, particularly for aesthetic medicine and surgery. Providing clinicians and researchers with relevant scientific data will support a better understanding of the clinical efficacy of BoNT in medicine and surgery.
To this end, this Special Issue of Toxins on BoNT has been carefully compiled to provide scientific data on various clinical indications including facial aesthetic medicine and cosmetic surgery, non-surgical body contouring, hypertrophic scars and keloids, pain control, and rehabilitation medicine. Active uses of BoNT for treating common dermatological conditions such as acne and rosacea will also be reviewed. A discussion of the current practice patterns and over-the-edge uses of BoNT will be included.
The advances seen in clinical uses of BoNT over the past 30 years are in large part owing to the investigations in the field. Through these studies, clinical results have been further optimized and complications are reduced. Appreciation should go to every researcher and clinician in this rapidly growing field who continue to expand our collective knowledge.
Prof. Hee-Jin Kim
Dr. Nark-Kyoung Rho
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- botulinum toxins
- clinical studies
- off-label use
- plastic surgery
- practice patterns
- regional anatomy
- rehabilitation medicine